Trial intelligence / Profile preview

Aspirin/Folate Prevention of Large Bowel Polyps

NCT00272324Phase 3Completed

Sponsor
Dartmouth Health
Start
Feb 1992
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
2
01

Overview

Phase 3, randomised, double-blind trial of aspirin and folic acid in Colorectal Adenoma (CRA) (6 arms), sponsored by Dartmouth Health. Primary endpoint: Proportion of subjects with 1 or more recurrent adenomas at 8 years. Started Feb 1992; status: completed.

02

Drugs

aspirinfolic acid
03

Conditions

Colorectal Adenoma (CRA)

Beyond the preview

Go deeper on NCT00272324.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00272324.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call